Abstract:The manifestations of cancerous phenotypes necessitate alterations at different levels of information-flow from genome to proteome. The molecular alterations at different information processing levels serve as the basis for the cancer phenotype to emerge. To understand the underlying mechanisms that drive the acquisition of cancer hallmarks it is required to interrogate cancer cells using multiple levels of information flow represented by different omics – such as genomics, epigenomics, transcriptomics, and proteomics. The advantage of multi-omics data integration comes with a trade-off in the form of an added layer of complexity originating from inherently diverse types of omics-datasets that may pose a challenge to integrate the omics-data in a biologically meaningful manner. The plethora of cancer-specific online omics-data resources, if able to be integrated efficiently and systematically, may facilitate the generation of new biological insights for cancer research. In this review, we provide a comprehensive overview of the online single- and multi-omics resources that are dedicated to cancer. We catalog various online omics-data resources such as The Cancer Genome Atlas (TCGA) along with various TCGA-associated data portals and tools for multi-omics analysis and visualization, the International Cancer Genome Consortium (ICGC), Catalogue of Somatic Mutations in Cancer (COSMIC), The Pathology Atlas, Gene Expression Omnibus (GEO), and PRoteomics IDEntifications (PRIDE). By comparing the strengths and limitations of the respective online resources, we aim to highlight the current biological and technological challenges and possible strategies to overcome these challenges. We outline the available schemes for the integration of the multi-omics dimensions for stratifying cancer patients and biomarker prediction based on the integrated molecular-signatures of cancer. Finally, we propose the multi-omics driven systems-biology approaches to realize the potential of precision onco-medicine as the future of cancer research. We believe this systematic review will encourage scientists and clinicians worldwide to utilize the online resources to explore and integrate the available omics datasets that may provide a window of opportunity to generate new biological insights and contribute to the advancement of the field of cancer research.

Data-driven approaches to advance research and clinical care for pediatric cancer

Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology

Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research

Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities

Recent Advancements and Innovations in Pediatric Precision Oncology

From Data to Cure: A Comprehensive Exploration of Multi-omics Data Analysis for Targeted Therapies

Developmental origins shape the paediatric cancer genome

St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem

Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra

Hospital-wide access to genomic data advanced pediatric rare disease research and clinical outcomes

Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors

Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae

Radio-pathomic approaches in pediatric neuro-oncology: Opportunities and challenges

Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities

Molecular Markers of Pediatric Solid Tumors—Diagnosis, Optimizing Treatments, and Determining Susceptibility: Current State and Future Directions

Recent Advances in Pediatric Cancer Research

Integration of Online Omics-Data Resources for Cancer Research

The Childhood Cancer Data Initiative: Using the Power of Data to Learn from and Improve Outcomes for Every Child and Young Adult with Pediatric Cancer

[PERSPECTIVES] Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress

Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration

Targeted treatment of solid tumors in pediatric precision oncology